chr22-17109514-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014339.7(IL17RA):​c.2295G>A​(p.Gln765Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0045 in 1,599,924 control chromosomes in the GnomAD database, including 281 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 150 hom., cov: 34)
Exomes 𝑓: 0.0023 ( 131 hom. )

Consequence

IL17RA
NM_014339.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.43

Publications

0 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 22-17109514-G-A is Benign according to our data. Variant chr22-17109514-G-A is described in ClinVar as Benign. ClinVar VariationId is 340611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.2295G>A p.Gln765Gln synonymous_variant Exon 13 of 13 ENST00000319363.11 NP_055154.3 Q96F46-1
IL17RANM_001289905.2 linkc.2193G>A p.Gln731Gln synonymous_variant Exon 12 of 12 NP_001276834.1 Q96F46-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.2295G>A p.Gln765Gln synonymous_variant Exon 13 of 13 1 NM_014339.7 ENSP00000320936.6 Q96F46-1
IL17RAENST00000612619.2 linkc.2193G>A p.Gln731Gln synonymous_variant Exon 12 of 12 5 ENSP00000479970.1 Q96F46-2

Frequencies

GnomAD3 genomes
AF:
0.0248
AC:
3782
AN:
152206
Hom.:
150
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0865
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00896
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0186
GnomAD2 exomes
AF:
0.00595
AC:
1318
AN:
221500
AF XY:
0.00408
show subpopulations
Gnomad AFR exome
AF:
0.0883
Gnomad AMR exome
AF:
0.00383
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000124
Gnomad OTH exome
AF:
0.00380
GnomAD4 exome
AF:
0.00234
AC:
3390
AN:
1447600
Hom.:
131
Cov.:
35
AF XY:
0.00191
AC XY:
1373
AN XY:
718924
show subpopulations
African (AFR)
AF:
0.0847
AC:
2811
AN:
33180
American (AMR)
AF:
0.00449
AC:
193
AN:
42940
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25722
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39172
South Asian (SAS)
AF:
0.000142
AC:
12
AN:
84638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51450
Middle Eastern (MID)
AF:
0.00317
AC:
18
AN:
5682
European-Non Finnish (NFE)
AF:
0.0000516
AC:
57
AN:
1105114
Other (OTH)
AF:
0.00501
AC:
299
AN:
59702
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
219
439
658
878
1097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0250
AC:
3803
AN:
152324
Hom.:
150
Cov.:
34
AF XY:
0.0236
AC XY:
1755
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0868
AC:
3607
AN:
41560
American (AMR)
AF:
0.00895
AC:
137
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68018
Other (OTH)
AF:
0.0184
AC:
39
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
171
342
513
684
855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
23
Bravo
AF:
0.0284
Asia WGS
AF:
0.00404
AC:
15
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 51 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

IL17RA-related disorder Benign:1
Apr 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.93
DANN
Benign
0.68
PhyloP100
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41482444; hg19: chr22-17590404; API